OpGen News - OPGN

Company Name	Stock Ticker Symbol	Market	Type
OpGen Inc	OPGN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.033	-5.86%	0.53	10:03:38

Open Price	Low Price	High Price	Close Price	Prev Close
0.5552	0.53	0.5552		0.563

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/23/2024	16:15	GLOBE	OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
3/26/2024	16:20	APS	Shares Rip In Reaction To Activist Investor Becoming CEO
3/25/2024	16:05	GLOBE	OpGen Announces Acquisition of Preferred Stock by David..
2/13/2024	16:30	EDGAR2	Form 8-K - Current report
2/08/2024	07:30	EDGAR2	Form 8-K - Current report
1/09/2024	16:30	EDGAR2	Form 8-K - Current report
12/12/2023	16:58	EDGAR2	Form 8-K - Current report
12/05/2023	16:37	EDGAR2	Form 8-K - Current report
11/24/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/14/2023	16:30	GLOBE	OpGen Reports Third Quarter 2023 Financial Results and..
11/13/2023	16:59	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/07/2023	16:30	EDGAR2	Form 8-K - Current report
10/26/2023	16:30	EDGAR2	Form 8-K - Current report
10/16/2023	16:30	EDGAR2	Form 8-K - Current report
10/13/2023	17:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/2023	17:17	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/13/2023	17:15	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/2023	17:14	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/2023	17:13	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/12/2023	12:32	GLOBE	OpGen Enters Into Warrant Inducement Transaction for up to..
10/11/2023	16:40	EDGAR2	Form 8-K - Current report
10/11/2023	16:30	EDGAR2	Form 8-K - Current report
9/28/2023	16:24	EDGAR2	Form RW - Registration Withdrawal Request
9/08/2023	16:30	EDGAR2	Form 8-K - Current report
9/07/2023	16:30	EDGAR2	Form 8-K - Current report
8/14/2023	08:45	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:31	EDGAR2	Form 8-K - Current report
8/10/2023	16:15	GLOBE	OpGen Reports Second Quarter 2023 Financial Results and..
8/07/2023	07:30	GLOBE	OpGen’s Subsidiary Ares Genetics Releases New Features to..
8/03/2023	08:00	GLOBE	OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
8/03/2023	07:30	GLOBE	OpGen to Provide Business Update and Financial Results for..
8/01/2023	09:40	EDGAR2	Form DEF 14A - Other definitive proxy statements
7/21/2023	16:55	EDGAR2	Form PRE 14A - Other preliminary proxy statements
7/19/2023	07:30	GLOBE	OpGen’s Subsidiary Curetis Meets Milestones of Extended and..
7/14/2023	16:30	EDGAR2	Form S-1 - General form for registration of securities under..
7/05/2023	16:30	EDGAR2	Form 8-K - Current report
6/30/2023	16:30	EDGAR2	Form 8-K - Current report
6/26/2023	07:30	GLOBE	OpGen Subsidiary Ares Genetics Successfully Maintains Key..
6/22/2023	07:30	GLOBE	OpGen’s Subsidiary Curetis Receives Batch of Ten New..
6/20/2023	07:30	GLOBE	OpGen Presents Unyvero Urinary Tract Infection Panel Trial..
5/15/2023	16:15	GLOBE	OpGen Reports First Quarter 2023 Financial Results and..
5/08/2023	07:30	GLOBE	OpGen to Provide Business Update and Financial Results for..
5/04/2023	16:30	GLOBE	OpGen Announces Closing of $3.5 Million Public Offering
5/01/2023	21:00	GLOBE	OpGen Announces Pricing of $3.5 Million Public Offering
4/26/2023	16:30	GLOBE	OpGen’s Subsidiary Curetis Meets All Remaining Key..